In NAFLD, it functions oppositely in hepatocytes and macrophages, exacerbating hepatic steatosis through the GH signaling pathway in hepatocytes, while inhibiting inflammation in macrophages by limiting the NF-κB signaling and inflammasome pathways [29,30]. Here, NFKB1 is linked to fatty liver disease.